Search: id:"swepub:oai:lup.lub.lu.se:84ccbdc3-5858-4b6e-ae97-9c45fedb6f1c" >
Association between...
-
Klintman, MarieLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
(author)
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
- Article/chapterEnglish2010
Publisher, publication year, extent ...
-
2009-08-04
-
Springer Science and Business Media LLC,2010
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:84ccbdc3-5858-4b6e-ae97-9c45fedb6f1c
-
https://lup.lub.lu.se/record/1470053URI
-
https://doi.org/10.1007/s10549-009-0483-1DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
In a previous study from our laboratory, high tumor levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) have been associated with an adverse response to chemotherapy in metastatic breast cancer suggesting that TIMP-1, which is known to inhibit apoptosis, may be a new predictive marker in this disease. The purpose of this study was to investigate the association between TIMP-1 and objective response to chemotherapy in an independent patient population consisting of patients with metastatic breast cancer from Sweden and Denmark. TIMP-1 was measured using ELISA in 162 primary tumor extracts from patients who later developed metastatic breast cancer and these levels were related to the objective response to first-line chemotherapy. Increasing levels of TIMP-1 were associated with a decreasing probability of response to treatment, reaching borderline significance (OR = 1.59, 95% CI: 0.97-2.62, P = 0.07). This OR is very similar to the result from our previous study. Increasing levels of TIMP-1 were also associated with a shorter disease-free survival and overall survival, however, not statistically significant. The results from the present study support previous data that TIMP-1 is associated with objective response to chemotherapy for metastatic breast cancer.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Ornbjerg Würtz, Sidse
(author)
-
Christensen, Ib
(author)
-
Bræmer Hertel, Pernille
(author)
-
Fernö, MårtenLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)onk-mfe
(author)
-
Malmberg, Martin
(author)
-
Mouridsen, Henning
(author)
-
Cold, Frederik
(author)
-
Schrohl, Anne-Sofie
(author)
-
Foekens, John
(author)
-
Malmström, PerLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)onk-pma
(author)
-
Brünner, Nils
(author)
-
Bröstcancer-genetikSektion I
(creator_code:org_t)
Related titles
-
In:Breast Cancer Research and Treatment: Springer Science and Business Media LLC121, s. 365-3711573-72170167-6806
Internet link
Find in a library
To the university's database
- By the author/editor
-
Klintman, Marie
-
Ornbjerg Würtz, ...
-
Christensen, Ib
-
Bræmer Hertel, P ...
-
Fernö, Mårten
-
Malmberg, Martin
-
show more...
-
Mouridsen, Henni ...
-
Cold, Frederik
-
Schrohl, Anne-So ...
-
Foekens, John
-
Malmström, Per
-
Brünner, Nils
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Breast Cancer Re ...
- By the university
-
Lund University